Showing results (171-180 of 362) with videos related to

Sort By:
Pageof 37
BJU International|May 27, 2010
Validating bladder cancer xenograft bioluminescence with magnetic resonance imaging: the significance of hypoxia and necrosisPeter C Black, Anil Shetty, Gordon A Brown, et al.
European Urology Oncology|September 27, 2024
Lights and Shadows of Bacillus Calmette-Guérin (BCG)-exposed and BCG-unresponsive Definitions: A Practical OverviewLuca Afferi, Andrea Gallioli, Damiano Stracci, et al.
The Oncologist|April 8, 2016
Predictors of Timely Access of Oncology Services and Advanced-Stage Cancer in an HIV-Endemic SettingCarolyn A Brown, Gita Suneja, Neo Tapela, et al.
Clinical Genitourinary Cancer|June 1, 2017
Association of Distance to Treatment Facility With Survival and Quality Outcomes After Radical Cystectomy: A Multi-Institutional StudyAhmed Q Haddad, Ryan Hutchinson, Erika L Wood, et al.
Clinical Genitourinary Cancer|October 25, 2024
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 StudyMoritz J Reike, Daniele Raggi, Chiara Mercinelli, et al.
European Urology Oncology|April 17, 2023
Adaptive Immunity in Genitourinary CancersMadhuri Koti, Trinity Bivalacqua, Peter C Black, et al.
European Urology Focus|May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder CancerMoritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 21, 2016
Clinical outcomes following laparoscopic management of pT3 renal masses: A large, multi-institutional cohortJasmir G Nayak, Premal Patel, Jennifer Bjazevic, et al.
European Urology|May 31, 2023
Checkpoint Inhibitors in Urothelial Carcinoma-Future Directions and Biomarker SelectionJoshua J Meeks, Peter C Black, Matthew Galsky, et al.
The Journal of Urology|December 21, 2010
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancerPeter C Black, Gordon A Brown, Colin P Dinney, et al.
Pageof 37